Home/Filings/4/0001437749-20-020689
4//SEC Filing

DARGAN CHARLES K 4

Accession 0001437749-20-020689

CIK 0000880242other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 5:14 PM ET

Size

14.2 KB

Accession

0001437749-20-020689

Insider Transaction Report

Form 4
Period: 2020-09-30
DARGAN CHARLES K
Chief Financial Officer
Transactions
  • Award

    Option to purchase common stock

    2020-09-30+5,0003,618,286 total
    Exercise: $0.15From: 2020-09-30Exp: 2030-09-30Common stock (5,000 underlying)
Footnotes (2)
  • [F1]This Option was granted to Reporting Person to replace options to purchase 20,000 shares that had been issued approximately 10 years ago to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and the Issuer's current stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
  • [F2]This amount reflects, in addition to the reported option, grant, the expiration on July 31, 2020 and August 31, 2020, of options to purchase an aggregate 20,000 shares of common stock.

Issuer

BIOLARGO, INC.

CIK 0000880242

Entity typeother

Related Parties

1
  • filerCIK 0001112799

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 5:14 PM ET
Size
14.2 KB